Filing Details
- Accession Number:
- 0001209191-21-011874
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-18 16:37:12
- Reporting Period:
- 2021-02-16
- Accepted Time:
- 2021-02-18 16:37:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 924717 | Surmodics Inc | SRDX | Surgical & Medical Instruments & Apparatus (3841) | 411356149 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1487121 | J. Joseph Stich | 9924 West 74Th Street Eden Prairie MN 55344 | Svp, Hr And Gm, Ivd | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-02-16 | 2,016 | $51.50 | 48,546 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-16 | 484 | $52.51 | 48,062 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2020.
- Reflects the weighted average price of 2,016 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on February 16, 2021 with sale prices ranging from $51.00 to $51.94 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average price of 484 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on February 16, 2021 with sale prices ranging from $52.355 to $53.23 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
